No need for antimetabolites?

Article

No need for antimetabolites?

Combined phacoemulsification and trabeculectomy with releasable sutures can be performed safely and effectively in the absence of antimetabolites, according to a study published in the February 2006 issue of the British Journal of Ophthalmology.

The analysis of 251 eyes of 198 patients after a combined phaco/trabeculectomy procedure was carried out by Walter J. Stark, MD and colleagues of Wilmer Eye Institute, John Hopkins University, Baltimore, USA.Patients were followed up for, on average, 16 months and were evaluated for vision, intraocular pressure (IOP) and a series of glaucoma medications.

The investigators noted a mean postoperative decrease of 19.2% for IOP and 84.1% for a number of glaucoma medications; 85% of eyes required fewer glaucoma medications and 78% of eyes were medication free, with IOP control.

The authors concluded that the procedure is a safe, effective and stable alternative for patients with cataracts and glaucoma in the absence of antimetabolites.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.